l-carnitine type 2 diabetes Risks and benefits of carnitine supplementation in L-Carnitine – DR MARTIN'S NUTRITION

Back to Archived Journals Research and Reports in Neonatology Volume 6 Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives Authors Soler-Alfonso C, Bennett M, Ficicioglu C Received 3 June 2015 Accepted for publication 16 September 2015 Published 18 January 2016 Volume 2016:6 Pages 110 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 5 Editor who approved publication: Dr Robert Schelonka Claudia Soler-Alfonso, 1 Michael J Bennett, 2 Can Ficicioglu 1 1 Department of Pediatrics, Section of Metabolic Disease, 2 Department of Pathology and Laboratory Medicine, The Childrens Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA Abstract: Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common disorder associated with fatty acid oxidation

Antagonizing effect of AP-1 on glucocorticoid induction of urea cycle enzymes: a study of hyperammonemia in carnitine-deficient, juvenile visceral steatosis mice

L-Carnitine is considered one of the most widely used nutritional ingredients for both athletes and weight control programmes

Keep your top picks ready for later